Literature DB >> 17376897

Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro.

Stéphane Biacchesi1, Brian R Murphy, Peter L Collins, Ursula J Buchholz.   

Abstract

During the preparation of recombinant derivatives of the CAN97-83 clinical isolate of human metapneumovirus (HMPV), consensus nucleotide sequencing of the recovered RNA genomes provided evidence of frequent sequence heterogeneity at a number of genome positions. This heterogeneity was suggestive of sizable subpopulations containing mutations. An analysis of molecularly cloned cDNAs confirmed the presence of mixed populations. The biologically derived virus on which the recombinant system is based also contained sizeable mutant subpopulations, whose presence was confirmed by biological cloning and nucleotide sequencing. Most of the mutations occurred in the SH gene. For example, partial consensus sequencing of 40 independent preparations of recombinant HMPV (wild-type and various derivatives) showed that 31 of these preparations contained a total of 41 instances of small insertions in the SH gene and a total of five small insertions elsewhere. In each of these 31 preparations, there was at least one insert in SH that changed the reading frame and would yield a truncated protein. Nearly all of these insertions involved adding one or more A residues to various tracks of four or more A residues, with the most frequent site being a tract of seven A residues. There were also two instances of nucleotide deletions and numerous instances of nucleotide substitution point mutations, mostly in the SH gene. The occurrence of mutant subpopulations was greatly reduced by the replacement of the SH gene with a synthetic version in which these oligonucleotide tracts were eliminated by silent nucleotide changes. We suggest that we frequently detected subpopulations in which the expression of full-length SH protein was ablated because it provided a modest selective advantage to this clinical isolate in vitro. Adaptation involving the functional loss of a gene is unusual for an RNA virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376897      PMCID: PMC1900297          DOI: 10.1128/JVI.00128-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Analysis of the genomic sequence of a human metapneumovirus.

Authors:  Bernadette G van den Hoogen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

Review 2.  Live vaccines for human metapneumovirus designed by reverse genetics.

Authors:  Ursula J Buchholz; Kunio Nagashima; Brian R Murphy; Peter L Collins
Journal:  Expert Rev Vaccines       Date:  2006-10       Impact factor: 5.217

3.  Genetic diversity between human metapneumovirus subgroups.

Authors:  Stéphane Biacchesi; Mario H Skiadopoulos; Guy Boivin; Christopher T Hanson; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  Virology       Date:  2003-10-10       Impact factor: 3.616

4.  The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.

Authors:  Mario H Skiadopoulos; Stéphane Biacchesi; Ursula J Buchholz; Jeffrey M Riggs; Sonja R Surman; Emerito Amaro-Carambot; Josephine M McAuliffe; William R Elkins; Marisa St Claire; Peter L Collins; Brian R Murphy
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 5.  Clinical impact and diagnosis of human metapneumovirus infection.

Authors:  Bernadette G van den Hoogen; D M E Osterhaus; Ron A M Fouchier
Journal:  Pediatr Infect Dis J       Date:  2004-01       Impact factor: 2.129

Review 6.  The dsRNA binding protein family: critical roles, diverse cellular functions.

Authors:  Laura R Saunders; Glen N Barber
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

7.  Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes.

Authors:  Stéphane Biacchesi; Mario H Skiadopoulos; Kim C Tran; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  Virology       Date:  2004-04-10       Impact factor: 3.616

8.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

9.  Modeling the structure of the respiratory syncytial virus small hydrophobic protein by silent-mutation analysis of global searching molecular dynamics.

Authors:  Uzi Kochva; Hadas Leonov; Isaiah T Arkin
Journal:  Protein Sci       Date:  2003-12       Impact factor: 6.725

10.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

View more
  23 in total

1.  Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.

Authors:  Edita M Klimyte; Stacy E Smith; Pasqua Oreste; David Lembo; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

2.  Genomic analysis of four human metapneumovirus prototypes.

Authors:  Rohith Piyaratna; Sharon J Tollefson; John V Williams
Journal:  Virus Res       Date:  2011-06-28       Impact factor: 3.303

3.  The human metapneumovirus small hydrophobic protein has properties consistent with those of a viroporin and can modulate viral fusogenic activity.

Authors:  Cyril Masante; Farah El Najjar; Andres Chang; Angela Jones; Carole L Moncman; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

4.  Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activation.

Authors:  Cyril Le Nouën; Philippa Hillyer; Linda G Brock; Christine C Winter; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

5.  Generation and propagation of recombinant mumps viruses exhibiting an additional U residue in the homopolymeric U tract of the F gene-end signal.

Authors:  Christian J Sauder; Laurie Ngo; Vahan Simonyan; Yu Cong; Cheryl Zhang; Malen Link; Tahir Malik; Steven A Rubin
Journal:  Virus Genes       Date:  2015-05-12       Impact factor: 2.332

6.  Experimental infection of adults with recombinant wild-type human metapneumovirus.

Authors:  Kawsar R Talaat; Ruth A Karron; Bhagvanji Thumar; Bridget A McMahon; Alexander C Schmidt; Peter L Collins; Ursula J Buchholz
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

7.  A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.

Authors:  Anne L Hotard; Fyza Y Shaikh; Sujin Lee; Dan Yan; Michael N Teng; Richard K Plemper; James E Crowe; Martin L Moore
Journal:  Virology       Date:  2012-10-11       Impact factor: 3.616

8.  Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells.

Authors:  Cyril Le Nouën; Philippa Hillyer; Shirin Munir; Christine C Winter; Thomas McCarty; Alexander Bukreyev; Peter L Collins; Ronald L Rabin; Ursula J Buchholz
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

9.  DC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.

Authors:  Leah Gillespie; Kathleen Gerstenberg; Fernanda Ana-Sosa-Batiz; Matthew S Parsons; Rubaiyea Farrukee; Mark Krabbe; Kirsten Spann; Andrew G Brooks; Sarah L Londrigan; Patrick C Reading
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

10.  Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry.

Authors:  Rachel M Schowalter; Andres Chang; Jessica G Robach; Ursula J Buchholz; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.